CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies
Author:
Trinh ThuLe, Adams William A., Calescibetta Alexandra, Tu Nhan, Dalton Robert, So Tina, Wei Max, Ward Grace, Kostenko Elena, Christiansen Sean, Cen Ling, McLemore Amy, Reed Kayla, Whitting Junmin, Gilvary Danielle, Blanco Neale Lopez, Segura Carlos Moran, Nguyen Jonathan, Kandell Wendy, Chen Xianghong, Cheng Pingyan, Wright Gabriela M., Cress W. Douglas, Liu Jinghong, Wright Kenneth L., Wei Sheng, Eksioglu Erika A.ORCID
Subject
Multidisciplinary
Reference105 articles.
1. Overcoming resistance to natural killer cell based immunotherapies for solid tumors;Nayyar;Front. Oncol.,2019 2. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors;Rusakiewicz;Cancer Res.,2013 3. A long way to the battlefront: CAR T cell therapy against solid cancers;Wang;J. Cancer,2019 4. T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy;Melero;Cancer Discov.,2014 5. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|